An Ono Pharma drug for a type of tumor affecting tissues of the joints is now FDA approved, giving the Japanese company a product with dosing and safety advantages over the Daiichi Sankyo product that ...
Yes, you read that correctly, scientists are giving acetylcholine receptor drugs another whirl in Alzheimer’s. At the AD/PD conference, held March 17–21 in Copenhagen, Denmark, Manfred Windisch of NSC ...
NEW YORK, June 2, 2025 /PRNewswire/ -- The Alzheimer's Drug Discovery Foundation (ADDF) today announced an investment of up to $2M to expand a quality control program for blood and CSF biomarkers, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results